Home  /  Resource Library  /  Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study

Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study

Results of a phase I study investigating tafasitamab combined with lenalidomide for first line treatment of DLBCL.